drugset / Trial / NCT02068027

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy

NCT02068027

Phase 2 Completed 260 enrolled BioDelivery Sciences International
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to determine whether clonidine gel is an effective treatment for reducing the pain associated with painful diabetic neuropathy.

Timeline

Start
2014-03
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 3.9 mg Topical